Regencell Bioscience Holdings Stock Price Patterns
| RGC Stock | USD 31.15 2.13 7.34% |
Momentum 46
Impartial
Oversold | Overbought |
Using Regencell Bioscience hype-based prediction, you can estimate the value of Regencell Bioscience Holdings from the perspective of Regencell Bioscience response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Regencell Bioscience using Regencell Bioscience's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Regencell using crowd psychology based on the activity and movement of Regencell Bioscience's stock price.
Regencell Bioscience Short Interest
A significant increase or decrease in Regencell Bioscience's short interest from the previous month could be a good indicator of investor sentiment towards Regencell. Short interest can provide insight into the potential direction of Regencell Bioscience stock and how bullish or bearish investors feel about the market overall.
200 Day MA 17.6914 | Short Percent 0.014 | Short Ratio 0.84 | Shares Short Prior Month 924.7 K | 50 Day MA 25.0218 |
Regencell Bioscience Hype to Price Pattern
Investor biases related to Regencell Bioscience's public news can be used to forecast risks associated with an investment in Regencell. The trend in average sentiment can be used to explain how an investor holding Regencell can time the market purely based on public headlines and social activities around Regencell Bioscience Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Regencell Bioscience's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Regencell Bioscience.
Regencell Bioscience Implied Volatility | 2.54 |
Regencell Bioscience's implied volatility exposes the market's sentiment of Regencell Bioscience Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regencell Bioscience's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regencell Bioscience stock will not fluctuate a lot when Regencell Bioscience's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Regencell Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Regencell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Regencell Bioscience after-hype prediction price | USD 27.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Regencell contract
Based on the Rule 16, the options market is currently suggesting that Regencell Bioscience Holdings will have an average daily up or down price movement of about 0.16% per day over the life of the 2026-03-20 option contract. With Regencell Bioscience trading at USD 31.15, that is roughly USD 0.0495 . If you think that the market is fully incorporating Regencell Bioscience's daily price movement you should consider acquiring Regencell Bioscience Holdings options at the current volatility level of 2.54%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Regencell | Build AI portfolio with Regencell Stock |
Regencell Bioscience After-Hype Price Density Analysis
As far as predicting the price of Regencell Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regencell Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regencell Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regencell Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Regencell Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regencell Bioscience's historical news coverage. Regencell Bioscience's after-hype downside and upside margins for the prediction period are 14.16 and 41.32, respectively. We have considered Regencell Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regencell Bioscience is slightly risky at this time. Analysis and calculation of next after-hype price of Regencell Bioscience is based on 3 months time horizon.
Regencell Bioscience Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Regencell Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regencell Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regencell Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.25 | 13.49 | 5.49 | 2.74 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
31.15 | 27.74 | 15.96 |
|
Regencell Bioscience Hype Timeline
On the 13th of February 2026 Regencell Bioscience is traded for 31.15. The entity has historical hype elasticity of -5.49, and average elasticity to hype of competition of -2.74. Regencell is forecasted to decline in value after the next headline, with the price expected to drop to 27.74. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -15.96%, whereas the daily expected return is at this time at 2.25%. The volatility of related hype on Regencell Bioscience is about 1107.76%, with the expected price after the next announcement by competition of 28.41. About 89.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.15. Regencell Bioscience recorded a loss per share of 0.01. The entity last dividend was issued on the 1st of December 2017. The firm had 38:1 split on the 16th of June 2025. Considering the 90-day investment horizon the next forecasted press release will be in about 9 days. Check out Regencell Bioscience Basic Forecasting Models to cross-verify your projections.Regencell Bioscience Related Hype Analysis
Having access to credible news sources related to Regencell Bioscience's direct competition is more important than ever and may enhance your ability to predict Regencell Bioscience's future price movements. Getting to know how Regencell Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regencell Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CYTK | Cytokinetics | (1.12) | 7 per month | 2.31 | 0.03 | 4.25 | (3.67) | 12.08 | |
| ATR | AptarGroup | 0.00 | 0 per month | 1.13 | 0.14 | 2.93 | (1.51) | 8.45 | |
| GRFS | Grifols SA ADR | 0.06 | 3 per month | 1.66 | 0.04 | 3.23 | (3.28) | 8.28 | |
| ABVX | Abivax SA American | (9.61) | 8 per month | 3.39 | 0.06 | 6.94 | (6.09) | 29.38 | |
| RYTM | Rhythm Pharmaceuticals | 3.74 | 11 per month | 0.00 | (0.03) | 4.76 | (4.28) | 18.69 | |
| STVN | Stevanato Group SpA | (0.10) | 8 per month | 0.00 | (0.21) | 4.69 | (5.60) | 15.63 | |
| AXSM | Axsome Therapeutics | (0.47) | 8 per month | 1.36 | 0.12 | 4.20 | (2.46) | 26.78 | |
| NUVL | Nuvalent | (1.54) | 11 per month | 2.40 | 0.03 | 3.45 | (3.90) | 17.72 | |
| MASI | Masimo | (1.92) | 12 per month | 0.00 | (0.08) | 3.02 | (2.71) | 10.00 |
Regencell Bioscience Additional Predictive Modules
Most predictive techniques to examine Regencell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regencell using various technical indicators. When you analyze Regencell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Regencell Bioscience Predictive Indicators
The successful prediction of Regencell Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regencell Bioscience Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regencell Bioscience based on analysis of Regencell Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regencell Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regencell Bioscience's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |